- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
KVS Ram Rao appointed Granules India Joint MD, CEO
Rao has previously worked at various companies like Dr Reddys Laboratories, Jubilant Life Sciences and Gujarat Heavy Chemicals.
New Delhi: Drug firm Granules India on Tuesday announced the appointment of KVS Ram Rao as Joint Managing Director and Chief Executive Officer (CEO) of the company with effect from January 5, 2022. Rao has over two decades of experience in pharmaceutical and chemical industries."During the past few years, we have stressed the importance of building a company around the pillars of efficiency...
New Delhi: Drug firm Granules India on Tuesday announced the appointment of KVS Ram Rao as Joint Managing Director and Chief Executive Officer (CEO) of the company with effect from January 5, 2022.
Rao has over two decades of experience in pharmaceutical and chemical industries.
"During the past few years, we have stressed the importance of building a company around the pillars of efficiency and sustainability. Rao's varied experience in the areas of chemical and API businesses including R&D and manufacturing through adoption of innovative technology and best practices in sustainability, will further strengthen Granules' drive towards becoming a strong integrated manufacturer with unparalleled efficiencies,'' Granules India CMD Krishna Prasad Chigurupati said in a statement.
Also Read: Granules India secures USFDA nod for Prazosin Hydrochloride Capsules
Rao has previously worked at various companies like Dr Reddy's Laboratories, Jubilant Life Sciences and Gujarat Heavy Chemicals.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.